Wellington Biotechnology Long/Short Fund (Bermuda) L.P.

Wellington Biotechnology Long/Short Fund (Bermuda) L.P. is an investment fund structure domiciled in Hamilton, Bermuda. Funds hold LEIs in their own right, and GLEIF records who manages them rather than who owns them.

The LEI has been on record for 13 years, since 22 Nov 2012. That is about 5 years earlier than the median LEI in Bermuda, which dates from 2018 — an early adopter by local standards.

The next annual re-validation is due 17 Dec 2026, 79 days from now.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The LEI is issued and maintained by Ubisecure Oy, one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.